These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8215620)

  • 1. Methotrexate osteopathy in rheumatic disease.
    Preston SJ; Diamond T; Scott A; Laurent MR
    Ann Rheum Dis; 1993 Aug; 52(8):582-5. PubMed ID: 8215620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate osteopathy.
    Schwartz AM; Leonidas JC
    Skeletal Radiol; 1984; 11(1):13-6. PubMed ID: 6424236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate osteopathy, does it exist?
    Maenaut K; Westhovens R; Dequeker J
    J Rheumatol; 1996 Dec; 23(12):2156-9. PubMed ID: 8970056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate osteopathy in patients with osteosarcoma.
    Ecklund K; Laor T; Goorin AM; Connolly LP; Jaramillo D
    Radiology; 1997 Feb; 202(2):543-7. PubMed ID: 9015088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of methotrexate osteopathy in rheumatic musculoskeletal disease: A systematic review.
    Ruffer N; Krusche M; Beil FT; Amling M; Kötter I; Rolvien T
    Semin Arthritis Rheum; 2022 Feb; 52():151952. PubMed ID: 35038641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphogenesis of occupational fluoride osteopathy].
    Razumov VV; Klitsenko OA; Rykov VA; Danilov IP
    Med Tr Prom Ekol; 1997; (4):18-23. PubMed ID: 9190267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis.
    Zonneveld IM; Bakker WK; Dijkstra PF; Bos JD; van Soesbergen RM; Dinant HJ
    Arch Dermatol; 1996 Feb; 132(2):184-7. PubMed ID: 8629827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone histomorphometric changes in children with rheumatic disorders on chronic glucocorticoids.
    Harrington J; Holmyard D; Silverman E; Sochett E; Grynpas M
    Pediatr Rheumatol Online J; 2016 Nov; 14(1):58. PubMed ID: 27832795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medial tibial stress syndrome due to methotrexate osteopathy.
    Alonso-Bartolome P; Martinez-Taboada VM; Canga A; Blanco R
    Ann Rheum Dis; 2006 Jun; 65(6):832-3. PubMed ID: 16699055
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ossidesmosia in the x-ray picture of some bone and joint diseases (author's transl)].
    Sváb V
    Cesk Radiol; 1981 May; 35(3):203-12. PubMed ID: 6972815
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteopathy due to methotrexate.
    Koller A; Fill H; Kurz R; Riccabona G; Haas H
    Osterr Z Onkol; 1976 Sep; 3(3):63-9. PubMed ID: 1069959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Radiological Characterization of Patients with Immobilizing and Progressive Stress Fractures in Methotrexate Osteopathy.
    Rolvien T; Jandl NM; Stürznickel J; Beil FT; Kötter I; Oheim R; Lohse AW; Barvencik F; Amling M
    Calcif Tissue Int; 2021 Feb; 108(2):219-230. PubMed ID: 33064170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of bone disease after kidney transplantation: A prospective histomorphometric analysis of trabecular and cortical bone.
    Carvalho C; Magalhães J; Pereira L; Simões-Silva L; Castro-Ferreira I; Frazão JM
    Nephrology (Carlton); 2016 Jan; 21(1):55-61. PubMed ID: 26201946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three patients with a fracture during methotrexate use, possibly due to methotrexate osteopathy].
    van der Bijl AE; Zijlstra TR; Engelage AH; Posthuma BJ; van Veen GJ
    Ned Tijdschr Geneeskd; 2008 Oct; 152(43):2357-60. PubMed ID: 19024069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
    PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary experience with low-dose methotrexate in fibroblastic rheumatism.
    Vittecoq O; Mejjad O; da Silva F; Joly P; Thomine E; Lauret P; Thomine JM; le Loët X
    Arthritis Rheum; 1996 Dec; 39(12):2070-3. PubMed ID: 8961914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
    Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G
    Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrogenesis imperfecta ossium. A collagen defect causing osteomalacia.
    Frame B; Frost HM; Pak CY; Reynolds W; Argen RJ
    N Engl J Med; 1971 Sep; 285(14):769-72. PubMed ID: 5567261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.